 |
English
|
正體中文
|
简体中文
|
全文筆數/總筆數 : 29490/55136 (53%)
造訪人次 : 1853478
線上人數 : 435
|
|
|
資料載入中.....
|
請使用永久網址來引用或連結此文件:
http://ir.cmu.edu.tw/ir/handle/310903500/29663
|
| 題名: | Detection of recurrent nasopharyngeal carcinomas after radiotherapy with technetium-99m tetrofosmin single photon emission computed tomography in patients with indeterminate magnetic resonance imaging findings |
| 作者: | Weng, YC;Yen, RF;Tsai, MH;Wang, JJ;Ho, ST;Kao, CH |
| 貢獻者: | 附設醫院核子醫學部;China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan;China Med Univ Hosp, Dept Otolaryngol, Taichung, Taiwan;Taichung Vet Gen Hosp, Dept Radiat Oncol, Taichung, Taiwan;Natl Taiwan Univ Hosp, Dept Nucl Med, Taipei, Taiwan;Chie Mei Med Ctr, Dept Med Res, Tainan, Taiwan;Natl Def Med Ctr, Sch Med, Taipei, Taiwan |
| 日期: | 2003 |
| 上傳時間: | 2010-09-24 14:39:55 (UTC+8) |
| 出版者: | MARCEL DEKKER INC |
| 摘要: | Thallium-201 (Tl-201) is a recognized tumor-imaging agent; however, the usefulness of Tl-201 in prostate cancer has not been studied. The purpose of this preliminary study was to evaluate the efficacy of Tl-201 single-photon emission computed tomography (SPECT) imaging for differentiating prostate cancer from benign prostatic hyperplasia (BPH). Methods: Tl-201 pelvic SPECT was performed in 10 patients (aged 64-78 years) with biopsy-proven BPH before transurethral resection of the prostate and 15 patients (aged 65-81 years) with biopsy-proven prostate cancer prior to any therapeutic modality or invasive surgical procedures for treatment of their prostate cancer. Results: From the 15 patients with prostate cancer, Tl-201 pelvic SPECT detected prostate cancer in 13 (86.7%) but not in 2 (13.3%) patients with Gleason scores of 5 (2 + 3). In contrast, all 10 patients with BPH (100.0%) had negative results of Tl-201 pelvic SPECT. Conclusion: Our study showed that Tl-201 pelvic SPECT scan is very helpful in distinguishing between prostate cancer and BPH. |
| 關聯: | CANCER INVESTIGATION 21(5):695-700 |
| 顯示於類別: | [台中附設醫院] 期刊論文
|
在CMUR中所有的資料項目都受到原著作權保護.
|
